Prof Lemmens underscores large unmet medical need in intracerebral hemorrhage -- "Very encouraging" data from Phase 2a trial with lead asset BIOX-101 -- Bioxodes is preparing for a possibly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback